Frontline: Neuropilin‐1: a surface marker of regulatory T cells
Open Access
- 25 February 2004
- journal article
- highlights
- Published by Wiley in European Journal of Immunology
- Vol. 34 (3) , 623-630
- https://doi.org/10.1002/eji.200324799
Abstract
CD4+CD25+ regulatory T cells (Treg cells) control immune responsiveness to a large variety of antigens. The isolation and therapeutic manipulation of Treg cells requires the use of reliable surface receptors that are selectively up‐regulated in Treg cells. On the basis of global gene expression studies, we identified neuropilin‐1 (Nrp1) as a specific surface marker for CD4+CD25+ Treg cells. Nrp1, a receptor involved in axon guidance, angiogenesis, and the activation of T cells, is constitutively expressed on the surface of CD4+CD25+ Treg cells independently of their activation status. In contrast, Nrp1 expression is down‐regulated in naive CD4+CD25– T cells after TCR stimulation. Furthermore, CD4+Nrp1high T cells express high levels of Foxp3 and suppress CD4+CD25– T cells. Thus, Nrp1 constitutes a useful surface marker to distinguish Treg cells from both naive and recently activated CD4+CD25+ non‐regulatory T cells.Keywords
This publication has 21 references indexed in Scilit:
- Regulatory T cells in transplantation toleranceNature Reviews Immunology, 2003
- Control of Regulatory T Cell Development by the Transcription Factor Foxp3Science, 2003
- CD4+CD25+ Regulatory T Cells Can Mediate Suppressor Function in the Absence of Transforming Growth Factor β1 Production and ResponsivenessThe Journal of Experimental Medicine, 2002
- Origin of regulatory T cells with known specificity for antigenNature Immunology, 2002
- A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune responseNature Immunology, 2002
- CD4+CD25+ Immunoregulatory T CellsImmunity, 2002
- Homeostasis and anergy of CD4+CD25+ suppressor T cells in vivoNature Immunology, 2001
- Cell Contact–Dependent Immunosuppression by Cd4+Cd25+Regulatory T Cells Is Mediated by Cell Surface–Bound Transforming Growth Factor βThe Journal of Experimental Medicine, 2001
- Interleukin 10 Secretion and Impaired Effector Function of Major Histocompatibility Complex Class II–restricted T Cells Anergized In VivoThe Journal of Experimental Medicine, 1998
- Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.The Journal of Experimental Medicine, 1994